Russian coronavirus vaccine is 91.6% effective, trial results suggest

Russian coronavirus vaccine is 91.6% effective, trial results suggest

The Russian coronavirus vaccine is 91.6% effective, trial results suggest (Aaron Chown/PA)

Russia’s vaccine is 91.6% effective against symptomatic coronavirus, interim trial results suggest.

No serious adverse events were deemed to be associated with vaccination, and most reported adverse events were mild, including flu-like symptoms, pain at the injection site and weakness or low energy.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited